Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-28 @ 10:30 AM
Study NCT ID:
NCT01150357
Status:
COMPLETED
Last Update Posted:
2015-10-15
First Post:
2010-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-23
First Submit QC Date:
None
Study First Post Date:
2010-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-10
Results First Submit QC Date:
None
Results First Post Date:
2015-10-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-09-15
Last Update Post Date:
2015-10-15
Last Update Post Date Type:
ESTIMATED